My Go to Device Now is ANTERION
In this video highlight from ASCRS 2024, James Lewis, MD, describes Heidelberg Engineering's ANTERION as the “most exciting piece of equipment I’ve acquired in the last decade.”
In this video highlight from ASCRS 2024, James Lewis, MD, describes Heidelberg Engineering's ANTERION as the “most exciting piece of equipment I’ve acquired in the last decade.”
Beyond clinical management of retinal disease, OCT is an effective modality in the monitoring and assessment of severe ocular trauma cases, as outlined in this article from Robert Gentile, MD. Dr. Gentile describes how he utilizes OCT imaging to enable visualization and diagnosis for both open globe and closed globe injuries.
In this Healio Video Perspective from ASCRS 2024, Mitchell Dul, OD, describes his key takeaways as a principal investigator for ANTERION and why he believes the platform is a "game changer" for imaging.
Jeremiah Brown, MD, reviews the three types of patients he has identified as a priority to monitor closely for clinical signs of GA: symptomatic patients with vision-impairing lesions, those progressing toward GA, and patients showing initial signs of nascent GA.
To support World Glaucoma Week, on behalf of Heidelberg Engineering, Janice English interviewed Phillip Van Lear to raise awareness of the importance of early detection of glaucoma and treatment at the right time. Read about his personal journey and share it with your patients.
Advances in optical coherence tomography (OCT) technology, new treatments and innovative research are contributing to earlier detection of glaucoma. Uncover more about the importance of patient awareness, confident diagnosis and treatment at the right time in this captivating interview with Dr. Christian Mardin, Consultant Ophthalmologist at the Friedrich-Alexander University Erlangen-Nuremberg and Dr. Sanjay Asrani, Professor of Ophthalmology at Duke Eye Centre, North Carolina.
In this interview Dr. Arturo Chayet shares his experience on the implementation of ANTERION® with swept-source OCT technology in his medical practice.
Dr. Jillian Liu and Dr. Claire K. Wright break down a unique case study of a 16-year old female patient with recent blunt eye trauma OD which resulted in traumatic cyclodialysis OD, ultimately leading to the development of hypotony maculopathy OD.
Accessing additional data for premium IOL selection is essential for patient satisfaction, and this is where the recently FDA-approved Heidelberg Engineering’s ANTERION can play a valuable role.
In this video interview, Priya Vakharia, MD, describes a challenging case study that was presented at AAO 2023.